Q1 2022 Holdings
Filed 2022-05-13 | 220 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $300.6M | 953,238 | 19.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $200.8M | 1,229,563 | 13.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $173.3M | 3,913,947 | 11.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $146.7M | 2,179,253 | 9.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $120.2M | 4,129,292 | 7.8% |
| Caredx Inc(CDNA) | COM | 14167L103 | $85.5M | 2,311,176 | 5.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $61.6M | 141,351 | 4.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $55.6M | 660,635 | 3.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $50.5M | 311,500 | 3.3% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $43.7M | 3,145,293 | 2.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $40.6M | 72,009 | 2.6% |
| Atricure Inc(ATRC) | COM | 04963C209 | $39.3M | 598,605 | 2.5% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $35.9M | 126,406 | 2.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $33.4M | 582,821 | 2.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $29.8M | 2,405,825 | 1.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $29.8M | 719,482 | 1.9% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $27.3M | 607,614 | 1.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $19.1M | 111,766 | 1.2% |
| Avantor Inc(AVTR) | COM | 05352A100 | $17.3M | 512,216 | 1.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $9.1M | 3,293,000 | 0.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.8M | 74,600 | 0.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.7M | 22,350 | 0.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.5M | 111,700 | 0.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.5M | 69,000 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.6M | 36,500 | 0.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $1.3M | 54,500 | 0.1% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $1.1M | 40,900 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $386.3K | 1,480,253 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $367.4K | 9,918,073 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $283.4K | 3,023,451 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $282.4K | 1,639,349 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $226.1K | 2,847,400 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $209.9K | 3,429,619 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $202.2K | 411,637 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $192.1K | 1,622,927 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $187.1K | 620,068 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $155.9K | 305,701 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $138.7K | 3,576,486 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $129.8K | 1,116,508 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $128.3K | 2,049,205 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $120.2K | 234,900 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $117.7K | 440,225 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $117.5K | 754,981 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $117.3K | 3,918,962 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $107.5K | 912,785 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $106.1K | 398,189 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $105.4K | 396,405 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $104.7K | 357,062 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $102.0K | 397,506 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $101.0K | 3,052,404 | 0.0% |